Antibiotic line locks for central venous catheters in adult patients on haemodialysis
|
|
- Jonas Mosley
- 6 years ago
- Views:
Transcription
1 Trust Clinical Guidelines Derby Hospitals NHS Foundation Trust Antibiotic line locks for central venous catheters in adult patients on haemodialysis Introduction Reference No: Microbial colonisation of a haemodialysis catheter can trigger catheter related bloodstream infections (CRBSI) and may spread from catheter to the bloodstream. It is relatively common and can increase both hospital cost and length of patient stay. It is also a significant cause of morbidity and mortality among haemodialysis patients. Effective treatment of CRBSI requires catheter removal or exchange, however, in some patients, catheter salvage may be attempted. The decision to salvage the catheter depends on the clinical condition of a patient, continued need for the central venous catheter, pathogen involved and response to treatment. This guideline will not cover the decision to remove or salvage a central line catheter. The prophylactic use of antibiotic line lock has been shown to decrease the incidence of CRBSI in multiple reports. Antibiotic line locks are used in patients who have had a previous incidence of line sepsis. This strategy has no obvious consequences to exposure to antibiotics or vascular access function. It also proved to have a further beneficial implication on treatment cost due to reduced epoetin requirements. Aim and Purpose The aim of this guideline is to ensure that antibiotic line locks are used safely and appropriately to prevent catheter related bloodstream infections in haemodialysis patients. Scope All adult haemodialysis patients in the renal unit and ward 407 Antibiotic line lock Antibiotic line lock is the instillation of highly concentrated antibiotic solution into an intravascular catheter lumen to prevent catheter related bloodstream infections. Concentrations must be 100- to 1000-fold greater to kill the bacteria within a biofilm. The antibiotic solution is left in the catheter lumen for a period of time before aspiration. Higher concentrations are Trust Policy on the Development and Management of Clinical Practice Guidelines Page 1 of 5
2 directly delivered to the colonised line for a longer period of time and sterilisation of the line is enhanced. The length of dwelling time varies from four to six hours to three days, depending on the stability of the line lock or catheter access. There is a potential for the antibiotic to leak out into the systemic circulation but the total amount given in the line lock is only a small fraction of its therapeutic dose. Hence, this leakage can be considered to be not clinically important in adult patients. Antibiotic locks are received by haemodialysis patients following dialysis. This is used by patients with temporary dialysis access site (permacaths) and they remain in situ until the next dialysis session when they are replaced. Choice of antibiotic Gentamicin line lock is the first line option for haemodialysis patients in prevention of CRBSI within the Trust. However, taurolidine and citrate can also be used. Gentamicin Preparation of the line lock The constituents of the lock are, in order: Gentamicin 5mg (0.5ml of gentamicin 20mg/2ml injection) Heparin 5,000units (1ml of heparin 5000units/ml injection) Sodium chloride 0.9% 0.5ml (to total of 2ml for lock ) Line locks are prepared by a dialysis nurse. Administration of Gentamicin line lock 1. Line lumen contents must be aspirated before injecting the new line lock (not needed if this is the first time). This must be done before the line is used. Seek senior medical advice if it is not possible to aspirate the line. 2. Withdraw the gentamicin, heparin and sodium chloride 0.9% using appropriate syringe, in the order shown above. 3. With the use of a bioconnecter to connect the syringe to the line, instil the lock slowly into the line in a quantity sufficient to fill the lumen completely. 4. The lock is left inside the line until the next dialysis session. Alternatively, this can be left and removed every week. 5. At the start of the next dialysis session, remove quantity instilled previously using a syringe. Ensure that quantity removed corresponds to the quantity instilled to avoid the possibility of the catheter solution leaking into the bloodstream. Trust Policy on the Development and Management of Clinical Practice Guidelines Page 2 of 5
3 Monitoring Gentamicin levels are not checked. Monitor patients for any systemic adverse effects. Taurolock Taurolock is used for patients who had an adverse reaction and are intolerant to gentamicin or heparin. Taurolock contains taurolidine and citrate 4%. Taurolidine is a broad spectrum antibiotic and antiendotoxin that covers against gram-positive and gram-negative, anaerobes and fungi. Citrate is used as an anticoagulant but can also help improve antimicrobial activity. The FDA advises against use of citrate concentrations exceeding 4% as high concentration was shown to impair cardiac function. Majority of evidence for taurolidine and citrate line locks is in the prevention of CRBSI. Preparation of the line lock Taurolock vials (5mls) are supplied by pharmacy. Line locks are prepared by a dialysis nurse. Administration of Taurolock 1. Line lumen contents must be aspirated before injecting the new line lock. This must be done before the line is used. Seek senior medical advice if it is not possible to aspirate the line. 2. With the use of a bioconnecter to connect the syringe to the line, flush the line with 10ml of saline (Sodium Chloride 0.9%) at the end of each dialysis session. 3. Withdraw Taurolock from container using appropriate syringe. 4. Instill Taurolock slowly into the line in a quantity sufficient to fill the lumen completely (see Table 1 below). 5. Taurolock is left inside the line until the next dialysis session. Alternatively, this can be left and removed every week. 6. At the start of the next dialysis session, remove quantity instilled previously using a syringe. Ensure that quantity removed corresponds to the quantity instilled to avoid the possibility of the catheter solution leaking into the bloodstream. Monitoring Whilst instilling Taurolock solution, monitor for any signs of discomfort and tingling or burning. There is a potential for the antibiotic to leak out into the systemic circulation but the total amount given in the line lock is only a small fraction of its total dose. Hence, this leakage can be considered to be not clinically important in adult patients. Trust Policy on the Development and Management of Clinical Practice Guidelines Page 3 of 5
4 The Renal Unit uses the KIMAL 14F x 28cm Split Cath III which has divided lumens with volumes of 1.7ml (red end) and 1.8ml (blue end). This is mainly used in the unit for most haemodialysis patients with permacaths. Please ensure the correct volume is instilled into the line. The lumen volume is usually marked on the line itself. Ensure this is checked if the permacath stated above is not used. References McIntyre C, Hulme L, Taal M, Fluck R. Locking of tunnelled haemodialysis catheters with gentamicin and heparin. Kidney International. Vol 66 (2004), Berrington A, Gould K. Use of antibiotic locks to treat colonised central venous catheters. Journal of Antimicrobial Chemotherapy 2001; 48: VandenBussche H. Antibiotic lock therapy for treatment of catheter-related bloodstream infections. UpToDate The Renal Association. Haemodialysis Guidelines. Available at: Taurolock. Antimicrobial Catheter Lock System to Provide Patency and Infection Control. Available at: Taurolidine. Micromedex. February 2013 Lacey J. Antibiotic line lock locks for central venous catheters in adults. Draft update. May 2012 National electronic library for medicines. Medicines Q+As. Which antibiotics should be used to treat colonized central venous catheters and how should they be administered? August 2011 Trust Policy on the Development and Management of Clinical Practice Guidelines Page 4 of 5
5 Documentation Controls Development of Guidelines: Titles of staff or Group involved in development Consultation With: For Trust Guidelines must include the Directorate Clinical Governance group or equivalent Approved By; Title only Local Guidelines must be signed off by the Service Director All Trust Guidelines will be signed off by the Chair of the Clinical Guidelines Group Name and Position: Person signing off guidelines Approval Date: Review Date: 2 years Key Contact: Sue Shaw (Renal Pharmacist) Trust Policy on the Development and Management of Clinical Practice Guidelines Page 5 of 5
Management of Catheter Related Bloodstream Infection (CRBSI), including Antibiotic Lock Therapy.
Management of Catheter Related Bloodstream Infection (CRBSI), including Antibiotic Lock Therapy. Written by: Dr K Gajee, Consultant Microbiologist Date: June 2017 Approved by: Drugs & Therapeutics Committee
More informationpreventionof lumen occlusion
what s new in prevention of non-infective complications? preventionof lumen occlusion RYDER SCIENCE, Inc..medical biofilm research Marcia Ryder PhD MS RN original research presented in this presentation
More informationHaemodialysis central venous catheter-related sepsis management guideline Version 3. NAME M. Letheren Chair Clinical Effectiveness Advisory Group
Lancashire Teaching Hospitals NHS Foundation Trust Haemodialysis central venous catheter-related sepsis management guideline Version 3 AUTHOR APPROVED BY DATE AUTH REF. NO NAME REBG/00018/July12 Michael
More informationMedicines for people having dialysis
Patient Information: Medicines NHS Logo here Medicines for people having dialysis Health & care information you can trust The Information Standard Certified Member Working together for better patient information
More informationNOTTINGHAM CHILDREN S HOSPITAL Nursing Guideline. P07 Care and Management of Children with a Totally Implantable Venous Access Device (Portacath).
NOTTINGHAM CHILDREN S HOSPITAL Nursing Guideline P07 Care and Management of Children with a Totally Implantable Venous Access Device (Portacath). Introduction A Portacath is a central venous access device
More informationIntervention Training Groningen
Intervention Training Groningen Evidence-based practice to reduce CVC-related infections Outline Background Technology Best practice Summary Outline Background Technology Best practice Summary Sources
More informationCardiac Catheter Labs Intravenous Drug Therapy Guide
Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Cardiac Catheter Lab IV Medicines Guideline Helen Buxton ( Senior Cath Lab
More informationLRI Children s Hospital
Title: Prescribing in Cystic Fibrosis Page 1 of 10 LRI Children s Hospital Prescribing in Cystic Fibrosis Staff relevant to: Clinical staff working within the UHL Children s Hospital. Team & AWP approval
More informationESPEN Congress Brussels How to take care of central venous access devices (CVAD)? Eva Johansson
ESPEN Congress Brussels 2005 How to take care of central venous access devices (CVAD)? Eva Johansson How to take care of central venous access devices (CVAD)? Eva Johansson, RN, PhD Division of Hematology
More informationBPG 03: Continuous Renal Replacement Therapy (CRRT)
BPG 03: Continuous Renal Replacement Therapy (CRRT) Statement of Best Practice Patient s requiring Continuous Renal Replacement Therapy (CRRT) will receive appropriate therapy to meet their individual
More informationTHE CARE AND MAINTENANCE OF TOTALLY IMPLANTED VENOUS ACCESS DEVICES (PORTS)
Children s Hospital for Wales Department of Paediatric Respiratory Medicine and Cystic Fibrosis THE CARE AND MAINTENANCE OF TOTALLY IMPLANTED VENOUS ACCESS DEVICES (PORTS) This protocol applies to the
More informationAnti- Infective Solutions. Leading Development of Novel Anti-Infective Products in the Era of Increasing Bacterial Resistance
Anti- Infective Solutions Leading Development of Novel Anti-Infective Products in the Era of Increasing Bacterial Resistance Forward- Looking Statements This presentation contains certain statements that
More informationPACKAGE LEAFLET: INFORMATION FOR THE USER. Actilyse Cathflo 2 mg, poeder voor oplossing voor injectie en infusie. Alteplase
PACKAGE LEAFLET 1 PACKAGE LEAFLET: INFORMATION FOR THE USER Actilyse Cathflo 2 mg, poeder voor oplossing voor injectie en infusie Alteplase Read all of this leaflet carefully before you start using this
More informationPrevention of dialysis catheter infection
Prevention of dialysis catheter infection Date written: May 2012 Author: George Chin GUIDELINES a. We recommend application of either topical agents or intraluminal lock solutions in reduction of exit-site
More informationInfections per 1000 catheter days. Infections per 1000 catheter days. Jurewitsch. Simon. Gabe 2,1 0 2,3 0,5 11,5 2,5 0,2 10,8 0,8 5,6 0,5 6,5 6,2 1,6
4,3 6,5 0,2 5,6 0,5 2,1 0 11,5 2,5 8,0 1,5 5,2 0,6 6,2 1,6,8 0,8 2,3 0,5 Canaud Ditmer Sodemann Allon Betjes Vernon Kramenko Taylor Infections per 00 catheter days Gabe Infections per 00 catheter days
More informationSt George Hospital Renal Department Internal Policy
SUMMARY: TROUBLESHOOTING POOR BLOOD FLOW IN VASCATHS: Please see the flow chart at the end of the protocol describing possible causes to be considered and how to deal with these in a systematic fashion.
More informationMANAGEMENT OF HAEMODIALYSIS CATHETER RELATED BLOOD STREAM INFECTION
MANAGEMENT OF HAEMODIALYSIS CATHETER RELATED BLOOD STREAM INFECTION RRCV CMG Renal and Transplant Service 1. Introduction Catheter related blood stream infection (CR-BSI) is a common complication in patients
More informationGuideline for the Management of Continuous IV Vancomycin Infusion in Neonates on NICU A Clinical Guideline recommended for use
Guideline for the Management of Continuous IV Vancomycin Infusion in A Clinical Guideline recommended for use For Use in: By: For: Division responsible for document: Key words: Name and job title of document
More informationTHERAPEUTIC PLASMA EXCHANGE
THERAPEUTIC PLASMA EXCHANGE DIRECTORATE OF NEPHROLOGY AND TRANSPLANTATION Background and Indications Therapeutic plasma exchange (TPE) is an extracorporeal blood purification technique in which plasma
More informationNational Surveillance System for Dialysis Centre and Dialysis Associated Diseases
National Surveillance System for Dialysis Centre and Dialysis Associated Diseases Dr Richard Fluck Consultant Renal Physician & Clinical Director, Royal Derby Hospital UK RA Vascular Access Survey 2005
More informationDevelopment of Haemodialysis Trigger Tool and Patient Safety index to monitor harm events during haemodialysis treatments
Name /title of project and organisation Development of Haemodialysis Trigger Tool and Patient Safety index to monitor harm events during haemodialysis treatments Derby Teaching Hospitals NHS Foundation
More informationEmergency clamp should always be readily available in case of accidental catheter fracture
Note: Please see individual policies for further information. Flushing best practice: Always use a 10 diameter syringe or larger when first accessing and when flushing vascular access device (VAD) Use
More informationLifecath Twin & Dualyse/Trilyse Permanent and Temporary Renal Catheters
Lifecath Twin & Dualyse/Trilyse Permanent and Temporary Renal Catheters Accurate locking dose Excellent flow rates Safe connections vygon@vygon.co.uk www.vygon.co.uk Product Information Product Information
More informationClinical Practice Guideline on Central Venous Catheter Care for the Patient with Cancer
Clinical Practice Guideline on Central Venous Catheter Care for the Patient with Cancer COG Supportive Care Endorsed Guidelines Click here to see all the COG Supportive Care Endorsed Guidelines. DISCLAIMER
More informationMANITOBA RENAL PROGRAM
MANITOBA RENAL PROGRAM SUBJECT Use of Closed Needleless Access Device with Hemodialysis Central Venous Catheters (CVC) SECTION CODE 30.20.04 30.20 Vascular Access AUTHORIZATION Professional Advisory Committee,
More informationUse ideal body weight (IBW) unless actual body weight is less. Use the following equation to calculate IBW:
Amikacin is a partially restricted (amber) antibiotic for the treatment of infections due to gentamicin resistant Gram negative bacilli or as advised by microbiology. As with other aminoglycosides, therapeutic
More informationRenal Unit. Catheter Related Bacteraemia Guidelines
Renal Unit Policy Manager Drew Henderson Policy Group Renal Unit Policy Established 21/01/2014 Policy Review Period/Expiry 21/01/2015 Last Updated 21/01/2014 This policy does apply to Medical/Dental Staff
More informationIf viewing a printed copy of this policy, please note it could be expired. Got to to view current policies.
If viewing a printed copy of this policy, please note it could be expired. Got to www.fairview.org/fhipolicies to view current policies. Department Policy Code: D: PC-5555 Entity: Fairview Pharmacy Services
More informationMary Lou Garey MSN EMT-P MedFlight of Ohio
Mary Lou Garey MSN EMT-P MedFlight of Ohio Function Prolonged and frequent access to venous circulation Allows for patient to carry on normal life; decrease number of needle sticks Medications, parenteral
More informationGUIDELINES FOR PERFORMING AN INTRAPERITONEAL UROKINASE LOCK
GUIDELINES FOR PERFORMING AN INTRAPERITONEAL UROKINASE LOCK Contact Name and Job Title (author) Directorate & Speciality Jr Sr Vanessa Keill Diabetes, Infection, Renal and Cardiovascular Directorate (Renal
More informationST. DOMINIC-JACKSON MEMORIAL HOSPITAL JACKSON, MISSISSIPPI. CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT) HEPARIN ANTICOAGULATION Page 1 of 5
HEPARIN ANTICOAGULATION Page 1 of 5 Pharmacy Mnemonic: CRRTHEP1 PATIENT DATA: DIAGNOSIS: AKI ESRD Other: WEIGHT: Today: kg Admission Weight:: kg Dry Weight: kg Access TYPE: Temporary Dialysis Catheter
More informationJVA ISSN Introduction REVIEW
JVA ISSN 1129-7298 J Vasc Access 2016; 17 (6): 453-464 DOI: 10.5301/jva.5000576 REVIEW Evidence-based criteria for the choice and the clinical use of the most appropriate lock solutions for central venous
More informationNavigating Vascular Access Issues
Navigating Vascular Access Issues The Oley Foundation 27 th Annual Consumer/Clinician Conference Redondo Beach, CA June, 27 2012 Anita Piano, BS, RN, VA-BC Administrative Nurse, PICC Service UCLA Health
More informationDirect Intravenous (IV) Medication Administration Procedure
Approved by: Chief Medical Officer; and Chief Operating Officer Direct Intravenous (IV) Medication Administration Procedure Corporate Policy & Procedures Manual Number: VII-B-310 Date Approved January
More informationCommon Medication for People Receiving Haemodialysis
Common Medication for People Receiving Haemodialysis Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm
More informationClinical Guidelines for Use of Antibiotics. VANCOMYCIN (Adult)
VANCOMYCIN (Adult) Please always prescribe VANCOMYCIN in the Variable Dose Antibiotic section of the EPMA SUPPLEMENTARY drug chart (and add a placeholder on the electronic drug chart). 1 Background Vancomycin
More informationINTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS
Title of guideline (must include the word Guideline (not protocol, policy, procedure etc) INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS Author: Contact Name and Job Title
More informationPREPARATION OF FISTULA NEEDLES TO COMMENCE HAEMODIALYSIS VIA AVF OR GRAFT AND REMOVAL OF NEEDLES AT END OF DIALYSIS SESSION
Nephrology Directorate Lower Lane Fazakerly L9 7AL PREPARATION OF FISTULA NEEDLES TO COMMENCE HAEMODIALYSIS VIA AVF OR GRAFT AND REMOVAL OF NEEDLES AT END OF DIALYSIS SESSION A) PREPARATION Wash hands
More informationOverview of CVADs. Type of device commonly used. Dwell time Flushing requirement Associated complications. lumens
Source: Clinical Skills Management of Vascular Access Devices Pre-course handbook. Adapted with permission from NHS Lothian Employee and Education Development Team. Overview of CVADs Type of device Veins
More informationPeritoneal Dialysis. Choosing your logo. V2.0 logos. information. you can trust. Certified Member. The Information Standard
Use of The Information Standard s Member Logos Peritoneal Dialysis Patient Information Choosing your logo The Information Standard has four logo versions for its members. They are designed to fit neatly
More informationPATIENT SAFETY ALERT
PATIENT SAFETY ALERT PROBLEM: Research in UK and elsewhere has identified a risk to patients from errors occurring during intravenous administration of potassium solutions. Potassium chloride concentrate
More informationMedical Emergencies in Dialysis Patients
Medical Emergencies in Dialysis Patients John Anderton Consultant Renal Physician Lancashire Teaching Hospitals NHS Foundation Trust Talk Plan A Flavour of Dialysis patients Emergencies in HD patients
More informationPrevention of dialysis catheter-related sepsis with a citrate taurolidine-containing lock solution
Nephrol Dial Transplant (2004) 19: 1546 1551 DOI: 10.1093/ndt/gfh014 Advance Access publication 19 February 2004 Original Article Prevention of dialysis catheter-related sepsis with a citrate taurolidine-containing
More informationNuovi materiali per la prevenzione di infezione e trombosi: quali evidenze?!
Nuovi materiali per la prevenzione di infezione e trombosi: quali evidenze?! Massimo Lamperti MD, MBA! Clinical Professor of Anesthesiology! Cleveland Clinic Lerner College of Medicine! Chief of General
More informationPeritoneal dialysis. Overview. Preparing for dialysis. Links to sections in topic Other topics available on website
Peritoneal dialysis This infokid topic is for parents and carers about children s kidney conditions. Visit www.infokid.org.uk to find more topics about conditions, tests & diagnosis, treatments and supporting
More informationTrust Guideline for the Use of Parenteral Vancomycin and Teicoplanin in Adults
A clinical guideline recommended for use: In: By: For: Division responsible for document: Key words: Names of document authors: Job titles of document authors: Name of document author s Line Manager: Job
More informationVenenkatheter-assoziierte Infektionen
Update Infektionen in der Hämatologie und Onkologie Venenkatheter-assoziierte Infektionen Georg Maschmeyer Potsdam www.dghoinfektionen.de Aktuelle Leitlinie der AGIHO...unter Berücksichtigung von: Ann
More informationPrevention of Hemodialysis Catheter- Related Bloodstream Infection Using an Antimicrobial Lock
Blood Purif 2002;20:87 92 Prevention of Hemodialysis Catheter- Related Bloodstream Infection Using an Antimicrobial Lock Francesco Quarello Giacomo Forneris Nephrology and Dialysis Unit, San Giovanni Bosco
More informationVascular access in practice: best practice update
Vascular access in practice: best practice update Nicola York Clinical Nurse Manager Vascular Access Oxford University Hospitals NHS Foundation Trust June 2016 Objectives Patient assessment Best practice
More informationFull title of guideline INTRAVENOUS VANCOMYCIN PRESCRIBING AND MONITORING GUIDELINE FOR ADULT PATIENTS. control
Full title of guideline Author: Contact Name and Job Title Division and specialty Scope Explicit definition of patient group to which it applies (e.g. inclusion and exclusion criteria, diagnosis) Changes
More informationDATE: 17 July 2012 CONTEXT AND POLICY ISSUES
TITLE: Sterile Pre-filled Saline Syringes for Acute Care Patients: A Review of Clinical Evidence, Cost-effectiveness, Evidence-based Guidelines, and Safety DATE: 17 July 2012 CONTEXT AND POLICY ISSUES
More informationEthanol Lock Technique: Review of the Literature
infection control and hospital epidemiology november 2009, vol. 30, no. 11 review article Ethanol Lock Technique: Review of the Literature Melissa Maiefski; Mark E. Rupp, MD; Elizabeth D. Hermsen, PharmD,
More informationEdinburgh Cancer Centre, Western General Hospital. Understanding Epirubicin, Oxaliplatin & 5-Fluorouracil Chemotherapy (EOF)
Introduction This booklet has been designed to help you and your family understand more about the chemotherapy that you are about to have as treatment for your cancer. If you need more information or have
More information02/10/2017. Major Infectious Complications. Learning Objectives. Modalities. At the end of this session the listener will be able to:
Major Infectious Complications Alicia M Neu, MD Chief, Division of Pediatric Nephrology Medical Director, Pediatric Dialysis and Kidney Transplantation The Johns Hopkins University School of Medicine The
More informationFundamentals of Flushing and Locking
Fundamentals of Flushing and Locking Vascular Access Devices Fundamentals of Flushing and Locking Purpose, Product, and Process 2016 BD. BD and the BD Logo are trademarks of Becton, Dickinson and Company.
More informationGuidelines for the use of Nebulised Colistemethate Sodium (Colomycin) Injection () in Pseudomonas aeruginosa Lung Infections in Adults
Index No: MMG41 Guidelines for the use of Nebulised Colistemethate Sodium (Colomycin) Injection () in Pseudomonas Version: 2 Date ratified: November 2017 Ratified by: (Name of Committee) Name of originator/author,
More informationIR Central Venous Access [ ] Pre Procedure
IR Central Venous Access [1050200001] Pre Procedure Case Request/Scheduling Procedure Enter IR Case Request if not already completed (All hospitals except Grant Medical Center) [ ] Case Request IR Lab
More informationNebulised (inhaled) Gentamicin
Newcastle Bronchiectasis Service Cardiothoracic Directorate Nebulised (inhaled) Gentamicin Your doctor has prescribed a drug called gentamicin for you. This is an inhaled drug, which is one that you breathe
More informationANTIMICROBIAL CATHETER LOCK SYSTEM TO PROVIDE PATENCY AND INFECTION CONTROL
ANTIMICROBIAL CATHETER LOCK SYSTEM TO PROVIDE PATENCY AND INFECTION CONTROL Prophylaxis against catheter related bloodstream infections: Central venous catheters (CVC) are used as short or long term vascular
More informationGastrostomy ( PEG ) tubes and the ED
Gastrostomy ( PEG ) tubes and the ED Percutaneous endoscopic gastrostomy (PEG) and radiology-inserted gastrostomy (RIG) have become the modality of choice for providing enteral access to patients who require
More informationTEMPORARY HEMODIALYSIS; TAUROLIDINE LOCK TO PREVENT CATHETER-RELATED BLOOD STREAM INFECTIONS
The Professional Medical Journal ORIGINAL PROF-2712 1. MBBS. Division of Nephrology, Department of Nephrology, 2. MD. Division of Nephrology, Department of Medicine, 3. MD. Division of Nephrology, Department
More informationIntravesical immunotherapy (known as BCG therapy): procedure-specific information
PATIENT INFORMATION Intravesical immunotherapy (known as BCG therapy): procedure-specific information What is the evidence base for this information? This leaflet includes advice from consensus panels,
More informationUniversity of Canberra. This thesis is available in print format from the University of Canberra Library.
University of Canberra This thesis is available in print format from the University of Canberra Library. If you are the author of this thesis and wish to have the whole thesis loaded here, please contact
More informationTissue Viability Service. Medical honey simplified. A patient guide to the role of honey in wound management
Medical honey simplified A patient guide to the role of honey in wound management Medical honey is a natural, non-toxic agent that has been used to treat wounds for thousands of years. This ancient remedy
More informationATI Skills Modules Checklist for Central Venous Access Devices
For faculty use only Educator s name Score Date ATI Skills Modules Checklist for Central Venous Access Devices Student s name Date Verify order Patient record Assess for procedure need Identify, gather,
More informationCentral Line Care and Management
Central Line Care and Management What is a Central Line/ CVAD? (central venous access device) A vascular infusion device that terminates at or close to the heart or in one of the great vessels (aorta,
More informationIV Vancomycin dosing and monitoring Antibiotic Guidelines. Contents. Intro
IV Vancomycin dosing and Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): as above Authors Division: DCSS & Tertiary Medicine Unique
More informationCaring for a Nephrostomy and what is Ureteric Stenting
Useful contacts: Macmillan Cancer Support Tel: 0808 808 00 00 www.macmillan.org.uk Buckinghamshire Healthcare NHS Trust Cancer Education, Information & Support Service Tel: 01296 316954 How can I help
More informationThe Impact of Catheter Occlusion in Central Line Associated Bloodstream Infections M A R C H 15, 2017
The Impact of Catheter Occlusion in Central Line Associated Bloodstream Infections D A R C Y DOELLMAN M S N, RN, CRNI, VA - BC M A R C H 15, 2017 LOUISVILLE, KENTUCKY Cincinnati Children s Hospital 642
More informationSouthern Trust Home IV Service. Guidelines for the administration of IV antibiotics
Southern Trust Home IV Service Guidelines for the administration of IV antibiotics Title: Author: CLINICAL GUIDELINES ID TAG Antibiotic guidelines - Southern Trust Home IV service guidelines for the administration
More informationCannulating AV Fistula using Buttonhole Technique
Nephrology Directorate Subject: Objective: Prepared by: Cannulating AV Fistula using Buttonhole Technique To enable the safe insertion and removal of needles into arteriovenous fistulae using the buttonhole
More informationTEXAS CHILDREN S HOSPITAL EVIDENCE-BASED OUTCOMES CENTER IV Lock Therapy Evidence Summary
TEXAS CHILDREN S HOSPITAL EVIDENCE-BASED OUTCOMES CENTER IV Lock Therapy Evidence Summary DATE: February 2014 Inclusion Criteria Infants/Children with long term central catheters who have a history of
More informationCentral Venous Catheter (CVC) Care for the Patient with Cancer. Clinical Practice Guideline
Central Venous Catheter (CVC) Care for the Patient with Cancer Clinical Practice Guideline Introduction & Context Stable venous access is used for a wide range of indications including chemotherapy, blood
More informationOperation-Fluids-Electrolytes-Acid Base COMPLICATIONS OF DIALYSIS 2
Operation-Fluids-Electrolytes-Acid Base COMPLICATIONS OF DIALYSIS 2 Maureen Craig, RN, MSN, CNN University of California Davis Medical Center Sacramento, California macraig@ucdavis.edu Hospital Details
More informationUnit 11. Objectives. Indications for IV Therapy. Intravenous Access Devices & Common IV Fluids. 3 categories. Maintenance Replacement Restoration
Unit 11 Fluids, Electrolytes and Acid Base Imbalances Intravenous Access Devices & Common IV Fluids Objectives Review the purpose and types of intravenous (IV) therapy. Recall the nursing care related
More informationCubicin A Guide to Dosing
Cubicin A Guide to Dosing Cubicin (Daptomycin) powder for solution for injection or infusion Indications (see SmPC) 1 : Cubicin is indicated for the treatment of the following infections (see sections
More informationCatalogue. Medication Safety Labels CONTENTS 1. For the Safe Management of Medication Version 2. Anaesthetic Syringe Labels
Medication Safety Labels Catalogue For the Safe Management of Medication Version 2 CONTENTS 1 4 8 11 12 Sterile Labels Injectable Medicines, Fluids & Line Labels Pre-printed Medicine Line Labels Anaesthetic
More informationIV Referral Standards for OPAT Services
pecialist harmacy ervice Medicines Use and afety IV Referral tandards for OAT ervices andra Wolper Associate Director Medicines Use and afety Division pecialist harmacy ervices pecialist harmacy ervice
More informationPlasma exchange. Information for patients Sheffield Kidney Institute (Renal Unit)
Plasma exchange Information for patients Sheffield Kidney Institute (Renal Unit) Plasma exchange This leaflet explains about plasma exchange; the benefits, risks, alternatives and what you can expect when
More informationINTRODUCTION CLINICAL EXPERIENCE CLINICAL EFFICACY PEDIATRIC EXPERIENCE DOSING SUMMARY
1 2 DOTAREM Administered Doses 3 Molecular Structure of DOTAREM DOTAREM offers high thermodynamic and kinetic stability provided by its macrocyclic and ionic structure* 3 *The clinical significance of
More informationCentral venous access in oncology: ESMO Clinical Practice Guidelines
Annals of Oncology 26 (Supplement 5): v152 v168, 2015 doi:10.1093/annonc/mdv296 Central venous access in oncology: ESMO Clinical Practice Guidelines B. Sousa 1, J. Furlanetto 2, M. Hutka 3, P. Gouveia
More informationBAXTER INITIATES VOLUNTARY NATIONWIDE RECALL OF SELECT LOTS OF IV SOLUTIONS DUE TO THE POTENTIAL FOR LEAKING CONTAINERS AND PARTICULATE MATTER
FOR IMMEDIATE RELEASE Media Contact: John O Malley (224) 948-5353 media@baxter.com Investor Contact: Clare Trachtman (224) 948-3085 BAXTER INITIATES VOLUNTARY NATIONWIDE RECALL OF SELECT LOTS OF IV SOLUTIONS
More informationVancomycin: Class: Antibiotic.
Vancomycin: Class: Antibiotic. Indications: Treatment of patients with infections caused by staphylococcal species and streptococcal Species. Available dosage form in the hospital: 1G VIAL, 500MG VIAL.
More information03/20/2019. Thank you for the invitation to speak. I have no conflicts of interest
Raj Munshi, MD Annual Dialysis Conference 2019 Thank you for the invitation to speak I have no conflicts of interest Expected remaining lifetime in years of prevalent patients by initial ESRD modality,
More informationBLOOD CULTURE POLICY FOR PAEDIATRICS
BLOOD CULTURE POLICY FOR PAEDIATRICS 1. INTRODUCTION Blood culture to detect bacteraemia is an important investigation with major implications for the diagnosis of patients with infection and the selection
More informationconcentrate intravenous solution and other strong potassium solutions
Policy for the use of potassium chloride concentrate intravenous solution and other strong potassium solutions CLINICAL GUIDELINES ID TAG Policy for the use of potassium chloride Title: concentrate intravenous
More informationSepsi: nuove definizioni, approccio diagnostico e terapia
GIORNATA MONDIALE DELLA SEPSI DIAGNOSI E GESTIONE CLINICA DELLA SEPSI Giovedì, 13 settembre 2018 Sepsi: nuove definizioni, approccio diagnostico e terapia Nicola Petrosillo Società Italiana Terapia Antiinfettiva
More informationThe C.L.O.T. Tool for Identifying Strategies to Prevent PICC Catheter Occlusions
The C.L.O.T. Tool for Identifying Strategies to Prevent PICC Catheter Occlusions page 2 TABLE OF CONTENTS Part 1: Definition and Scope of Catheter Occlusion Part 2: Predictors of Catheter Occlusion Part
More informationSkin tunnelled dialysis catheter (Tesio ) insertion
Skin tunnelled dialysis catheter (Tesio ) insertion This leaflet explains more about Tesio insertion, including the benefits, risks and any alternatives and what you can expect when you come to hospital.
More informationGuideline scope Neonatal parenteral nutrition
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Guideline scope Neonatal parenteral nutrition The Department of Health in England has asked NICE to develop a new guideline on parenteral nutrition in
More informationVirtual Lectures Planning Committee Disclosure Summary
Mayo Medical Laboratories Virtual Lectures 2014 MFMER MFMER Virtual Lectures Planning Committee Disclosure Summary As a provider accredited by ACCME, College of Medicine, Mayo Clinic (Mayo School of CPD)
More informationCHEMOTHERAPY NETWORK GROUP POLICY FOR ADMINISTRATION OF CYTOTOXIC CHEMOTHERAPY
CHEMOTHERAPY NETWORK GROUP POLICY FOR ADMINISTRATION OF CYTOTOXIC CHEMOTHERAPY Version 4.0 March 2016 Review date March 2018 Introduction It is the purpose of this policy to provide clear guidelines that
More informationHEMODIALYSIS CATHETERS - ANY CHANGES FOR 2018? BY ELIZABETH EVANS DNP 10TH ANNUAL NEPHROLOGY NURSING SYMPOSIUM ALBUQUERQUE, NM
HEMODIALYSIS CATHETERS - ANY CHANGES FOR 2018? BY ELIZABETH EVANS DNP 10TH ANNUAL NEPHROLOGY NURSING SYMPOSIUM ALBUQUERQUE, NM OBJECTIVES: 1. IDENTIFY ONE NEW HEMODIALYSIS CATHETER CARE PRACTICE 2. EVALUATE
More informationPackage leaflet: Information for the patient. NEGABAN 1g, powder for solution for injection or infusion Temocillin
Package leaflet: Information for the patient NEGABAN 1g, powder for solution for injection or infusion Temocillin Read all of this leaflet carefully before you start using this medicine because it contains
More informationThis guideline describes the care required for a patient receiving a red blood cell transfusion whilst undergoing extra corporeal therapies.
Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Guidelines for care of a patient receiving a red blood cell transfusion whilst undergoing extra corporeal therapies.
More informationIndex No: MMG11/1. Version: 1. Date ratified: 12 th November 2013
Index No: Intravenous fluid prescription in children For previously well children aged one month to 16 years (excluding renal, cardiac, diabetic ketoacidosis and acute burns patients) Version: 1 Date ratified:
More informationPROTOCOL FOR THE INSERTION OF NON TUNNELLED DIALYSIS CENTRAL VENOUS CATHETERS
PROTOCOL FOR THE INSERTION OF NON TUNNELLED DIALYSIS CENTRAL VENOUS CATHETERS Version 1.0 Author Vinod Mathrani, Kieron Donovan, Steve Riley, Soma Meran, Gareth Roberts, Vinod Ravindran Agreed 06/11/2015
More informationSuprapubic Catheter Insertion Clinic
Suprapubic Catheter Insertion Clinic Exceptional healthcare, personally delivered Suprapubic Catheter Why may I need a suprapubic catheter? A suprapubic catheter enters the bladder through an incision
More information